PRIVIGEN for Chronic inflammatory demyelinating polyradiculoneuropathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where PRIVIGEN was used for Chronic inflammatory demyelinating polyradiculoneuropathy.
Most Reported Side Effects for PRIVIGEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 30 | 18.1% | 0 | 14 |
| Chills | 23 | 13.9% | 0 | 7 |
| Pyrexia | 21 | 12.7% | 0 | 11 |
| Nausea | 18 | 10.8% | 0 | 8 |
| Pneumonia | 15 | 9.0% | 3 | 7 |
| Vomiting | 15 | 9.0% | 0 | 6 |
| Dyspnoea | 14 | 8.4% | 0 | 4 |
| Sinusitis | 14 | 8.4% | 0 | 6 |
| Hypertension | 12 | 7.2% | 0 | 5 |
| Rash | 12 | 7.2% | 0 | 5 |
| Blood pressure increased | 11 | 6.6% | 0 | 3 |
| Haemolysis | 10 | 6.0% | 1 | 3 |
| Chest pain | 9 | 5.4% | 0 | 6 |
| Tachycardia | 9 | 5.4% | 0 | 4 |
| Fatigue | 8 | 4.8% | 0 | 5 |
Other Indications for PRIVIGEN
Immunodeficiency common variable (24)
Hypogammaglobulinaemia (13)
Chronic lymphocytic leukaemia (11)
Secondary immunodeficiency (11)
Immune thrombocytopenic purpura (7)
Guillain-barre syndrome (6)
Immunodeficiency (5)
Other Drugs Used for Chronic inflammatory demyelinating polyradiculoneuropathy
HUMAN IMMUNOGLOBULIN G (4,735)
RITUXIMAB (245)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (88)
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC (81)
METHYLPREDNISOLONE (72)
AZATHIOPRINE (61)
MYCOPHENOLATE MOFETIL (59)
CYCLOPHOSPHAMIDE (55)
PREDNISONE (45)
BORTEZOMIB (40)